ArticleOncotarget2017

Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignancies.

Paolo F Caimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.